DeepUll
Barcelona
About DeepUll
DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition. DeepUll’s proposal is based on quickly identifying the pathogens and offering the antibiogram within a few hours on the one hand, and on using the data and learning about the patient’s immunological and functional status on the other. The system allows doctors to predict the future appearance and evolution of sepsis within a short period of time and thus provide a suitable clinical response even before the symptoms arise.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $113.0M
- Funding stage: Late Stage Venture
- Last round: Series C (Apr 2025)
- Website: deepull.com
- Phone: +34 93 655 3530
Industries & Categories
Biotechnology, Life Science
Social Profiles
Canonical: https://fsome.com/organization/deepull-22756 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.